← Back
$KURA All transactions

Kura Oncology, Inc.

▼ SELL 10b5-1 Plan

$ Value

$9K

Shares

1,559

Price

$6

Filed

May 19

Insider

Name

Bair Teresa Brophy

Title

Chief Legal Officer

CIK

0001813058

Roles

Officer

Transaction Details

Transaction Date

2025-05-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

107,948

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2024. | 1,559 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.

Filing Info

Accession No.

0000950170-25-074660

Form Type

4

Issuer CIK

0001422143

Bair Teresa Brophy's History

Date Ticker Type Value
2026-01-27 KURA $35K
2026-01-27 KURA $20K
2026-01-27 KURA $40K
2026-01-02 KURA A $0
2026-01-02 KURA A $0
2025-11-14 KURA $98K
2025-11-13 KURA A $0
2025-09-29 KURA $79K
2025-09-27 KURA A $0
2025-05-19 KURA $9K

Other Insiders at KURA (90d)

Insider Bought Sold Last
WILSON TROY EDWARD
President and CEO
2026-03-23
FORD KATHLEEN
Chief Operating Officer
$15K 2026-01-27
Bair Teresa Brophy
Chief Legal Officer
$95K 2026-01-27
DOYLE THOMAS JAMES
SVP, Finance & Accounting
$60K 2026-01-27
Powl Brian T.
Chief Commercial Officer
$54K 2026-01-27
Leoni Mollie
Chief Medical Officer
$69K 2026-01-27
Burrows Francis
Chief Scientific Officer
$11K 2026-01-27